Benjamin Edwards Inc. Acquires 2,775 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Benjamin Edwards Inc. lifted its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 18.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 17,942 shares of the financial services provider’s stock after acquiring an additional 2,775 shares during the quarter. Benjamin Edwards Inc.’s holdings in Trupanion were worth $527,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Intech Investment Management LLC acquired a new position in shares of Trupanion during the 2nd quarter worth approximately $291,000. Connors Investor Services Inc. grew its position in Trupanion by 31.3% during the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after buying an additional 27,042 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in Trupanion during the second quarter worth approximately $4,739,000. Dimensional Fund Advisors LP increased its stake in Trupanion by 24.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 137,833 shares of the financial services provider’s stock worth $4,052,000 after acquiring an additional 26,941 shares during the period. Finally, WINTON GROUP Ltd raised its holdings in Trupanion by 1.9% in the 2nd quarter. WINTON GROUP Ltd now owns 37,673 shares of the financial services provider’s stock valued at $1,108,000 after acquiring an additional 685 shares in the last quarter.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 624 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock valued at $405,238 in the last 90 days. 5.50% of the stock is owned by corporate insiders.

Trupanion Trading Up 1.9 %

TRUP opened at $42.80 on Friday. The company has a market cap of $1.80 billion, a P/E ratio of -66.88 and a beta of 1.74. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The company’s 50 day moving average is $40.56 and its 200-day moving average is $31.70. Trupanion, Inc. has a 1-year low of $19.14 and a 1-year high of $49.14.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. The firm had revenue of $314.80 million for the quarter, compared to analyst estimates of $309.33 million. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The company’s quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the business posted ($0.33) earnings per share. Equities research analysts predict that Trupanion, Inc. will post -0.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

TRUP has been the topic of a number of recent analyst reports. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday. Piper Sandler raised their target price on shares of Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a report on Friday, August 9th. Northland Securities upped their price target on shares of Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a report on Thursday. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Finally, William Blair assumed coverage on shares of Trupanion in a research report on Friday, July 19th. They set an “outperform” rating for the company. Four investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $39.00.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.